Cyclobenzaprine Hydrochloride
- Product NDC
- 50090-5326
- 11-digit product format
- 500905326
- Labeler code
- 50090
- Product ID
- 50090-5326_b9cf1305-6415-4f22-99dd-f2528e2503b1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077563
- Marketing category
- ANDA
- Marketing start
- 2017-10-09
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5326-1 | Cyclobenzaprine Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 4 |
| 50090-5326-2 | Cyclobenzaprine Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5326 | CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 4 | Legacy NDC, 2 package rows | 20220120_f77a095a-92b6-4809-952e-4feee415a5fc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5326-1 | 50090532601 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5326-1) | 2020-10-30 | 0000-00-00 | No | No | Current |
| 50090-5326-2 | 50090532602 | 60 TABLET, FILM COATED in 1 BOTTLE (50090-5326-2) | 2020-10-30 | 0000-00-00 | No | No | Current |